Key facts
- This page summarizes William Moschella's Form 4 filing for Definitive Healthcare Corp. (DH).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2025, 18:56.
William Moschella - 21 Jan 2025 Form 4 Insider Report for Definitive Healthcare Corp. (DH)
- Reporting relationship
- Chief Product & Tech Officer
- Issuer ticker
- DH
- Reported as of
- 21 Jan 2025
- Net transaction value
- -$168,290
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 18:56:25 UTC
- Prior SEC filing
- 03 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Ruderman, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William Moschella filed Form 4 for Definitive Healthcare Corp. (DH) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 03 Jan 2025.
- Current net transaction value: -$168,290.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DH
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +66,142
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 486,551
- Date
- 21 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
DH
transaction
Class A Common Stock
Tax liability
- Transaction value
- $29,596
- Shares
- -6,711
- Change %
- -1.4%
- Price
- $4.41
- Shares after
- 479,840
- Date
- 21 Jan 2025
- Ownership
- Direct
- Footnotes
- F2
DH
transaction
Class A Common Stock
Tax liability
- Transaction value
- $138,695
- Shares
- -28,538
- Change %
- -5.9%
- Price
- $4.86
- Shares after
- 451,302
- Date
- 01 Feb 2025
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects the number of performance-based restricted stock units ("PSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, earned upon the certification of achievement of certain performance criteria by the Issuer's compensation committee. The PSUs will vest in three substantially equal installments as to 1/3rd on January 21, 2025, 1/3rd on February 1, 2026, and the remaining 1/3rd on February 1, 2027 and will be settled pursuant to the terms of the Issuer's 2021 Equity Incentive Plan (as amended from time to time), in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date.
Footnote F2
Represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of previously reported PSUs.
Footnote F3
Represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.